About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Houston | 22,469 Studies Near You

Clinical TrialsHouston

Clinical Trials in Houston

Discover 22,469 clinical trials near Houston, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 501-520 of 22,469 trials

CompletedA Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With FibromyalgiaThe purpose of this study is to assess the safety and effectiveness of \[S,S\]-Reboxetine in patients with fibromyalgia.NCT00357825·Chandler, Arizona and 60 others

Find Trials by Condition in Houston

Breast Cancerin Houston Lung Cancerin Houston Prostate Cancerin Houston Colorectal Cancerin Houston Melanomain Houston Leukemiain Houston Lymphomain Houston Pancreatic Cancerin Houston Ovarian Cancerin Houston Brain Cancerin Houston Diabetes

Data from ClinicalTrials.govTerms

CompletedComparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital WartsA clinical endpoint bioequivalence (BE) study for a Podofilox Gel 0.5% formulation for the treatment of external anogenital warts in comparison to Condylox® Gel 0.5% that follows…NCT03532776·Miami, Florida and 16 others

TerminatedStudy of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast CancerThis is a first-in-human, open-label, Phase 1 study evaluating BBI-940, an investigational kinesin oral molecular degrader, administered as monotherapy or in combination with…NCT07408089·Los Angeles, California and 7 others

TerminatedImatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML PatientsPrimary Objective: To estimate the probability of molecular complete remission at one year for the described sequential treatment approach, with nonablative hematopoietic…NCT00499889·Houston, Texas

CompletedExtended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213Extended Treatment and Follow-up of Subjects Treated with Belumosudil in Study KD025-208 or Study KD025-213NCT05305989·Duarte, California and 7 others

Active not recruitingA Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or RecurrenceThe trial aims to collect safety, efficacy, exposure, dose- response, pharmacokinetic and pharmacodynamic information of the combination of L19TNF and lomustine at different dose…NCT06336291·Chicago, Illinois and 8 others

TerminatedHuman Optokinetic Contrast Device (HOCD) to Measure Visual Function and Identify Patients With and Without GlaucomaThe purpose of this study is to determine if an optokinetic contrast detection device is sufficient to measure contrast sensitivity and to distinguish between patients with and…NCT02014597·Houston, Texas

CompletedMild and Rapidly Improving Stroke StudyThe objective of this study is to determine the 90-day outcomes of mild and rapidly improving ischemic stroke.NCT02072681·Chandler, Arizona and 96 others

CompletedSafety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)This clinical trial is designed to provide additional information on the safety and tolerability of vildagliptin (50 mg once daily (qd)) and sitagliptin (25 mg qd) when used in…NCT00770081·Mobile, Alabama and 86 others

CompletedA Study of LY3502970 in Participants With Type 2 Diabetes MellitusThe main purpose of this study is to evaluate the efficacy and safety of LY3502970 in participants with type 2 diabetes (T2D) who failed to achieve adequate glycemic control on…NCT05048719·Anaheim, California and 43 others

CompletedA Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerThis is a Phase III, global, double-blind, 2-arm randomized study designed to compare the efficacy and safety of atezolizumab + paclitaxel + carboplatin + bevacizumab versus…NCT03038100·Phoenix, Arizona and 267 others

TerminatedTXA127 in Enhancement of Engraftment in Adult Double Cord Blood TransplantationThe purpose of this study is to evaluate the effect of TXA127 on neutrophil and platelet counts in adult patients who have undergone a double cord blood transplant.NCT01300611·Houston, Texas

RecruitingSignatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerThe purpose of this study is to evaluate the efficacy and safety of ctDNA-guided initiation of CDK4/6 inhibitor therapy using the Signatera™ Designed on Genome test (referred to…NCT07214532·Phoenix, Arizona and 48 others

Unknown304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone DeficiencyThe purpose of the proposed study is to investigate the effects of rhGH treatment on glucose, protein and fat metabolism in GHD children.NCT00362063·Houston, Texas

Active not recruitingA Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA NaïveThe purpose of this study is to determine the effectiveness of luspatercept (ACE-536) compared to epoetin alfa on red blood cell (RBC) transfusion independence (for at least 12…NCT03682536·Berkeley, California and 225 others

Active not recruitingHarmony & Health: Feasibility of a Movement Intervention to Improve Psychosocial Wellbeing in Black Adults in Northeast TexasTo test the feasibility and acceptability of a program that combines yoga practices and Christian spirituality (called Harmony \& Health) amongst insufficiently active Black…NCT05761964·Houston, Texas

CompletedStudy to Evaluate Efficacy and Safety of Ropanicant in MDD PatientsThe primary objective is to evaluate the efficacy of Ropanicant at two different dosage levels compared to placebo in patients with Major Depressive Disorder (MDD).NCT06836063·Little Rock, Arkansas and 34 others

CompletedMultiple Ascending Dose Study of PRX002 in Patients With Parkinson's DiseaseThis multiple ascending dose study is to determine safety, tolerability, pharmacokinetics and immunogenicity of PRX002 in approximately 60 patients with Parkinson's disease.NCT02157714·Long Beach, California and 7 others

CompletedStudy of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)This is a Phase 3, international, multicenter, randomized, double-blind, placebo-controlled, efficacy and safety study of ataluren in patients with nonsense mutation cystic…NCT02139306·Birmingham, Alabama and 87 others

CompletedLapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In SituThis randomized phase I/II trial studies the side effects and best dose of lapatinib ditosylate and to see how well it works in treating patients with ductal breast carcinoma in…NCT00555152·Birmingham, Alabama and 1 other

PreviousPage 26 of 1124Next

in Houston

Heart Diseasein Houston